EPB0200	Lower prevalence of potential drug-drug interactions among people living with HIV in the era of integrase inhibitor-based antiretroviral therapy	E-poster	HIV and ageing
EPB0201	Aging of brain network connectivity corresponds to cognitive impairment in persons with HIV	E-poster	HIV and ageing
EPB0202	Measuring intrinsic capacity: a screening tool for integrated care in ageing people living with HIV	E-poster	HIV and ageing
EPB0203	Frailty transition among older adults living with HIV in Thailand: a five-year prospective cohort study	E-poster	HIV and ageing
EPB0204	Incidence of infections across Islatravir clinical development programs	E-poster	Antiretroviral therapies and clinical issues in adults
EPB0205	The relationship between gender-affirming hormone therapy and tenofovir dried blood spot concentrations among transgender adults switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for pre-exposure prophylaxis	E-poster	Antiretroviral therapies and clinical issues in adults
EPB0206	HIV treatment outcomes after 10 years on ART in the TREAT Asia Observational Database (TAHOD) and Australian HIV Observational Database (AHOD)	E-poster	Antiretroviral therapies and clinical issues in adults
EPB0207	Adverse pregnancy outcomes following dolutegravir transition among women delivering at surveillance sites in Eswatini	E-poster	Antiretroviral therapies and clinical issues in adults
EPB0208	Effect on weight changes upon discontinuation of dolutegravir from antiretroviral regimens among persons with HIV who experienced weight gain	E-poster	Antiretroviral therapies and clinical issues in adults
EPB0209	Real-world observational study in Europe on the effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor (COMBINE-2): week 96 stable switch population results	E-poster	Antiretroviral therapies and clinical issues in adults